These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 9714170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 3. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL, Story M.
    J Adolesc Health; 1998 Jun; 22(6):446-52. PubMed ID: 9627814
    [Abstract] [Full Text] [Related]

  • 4. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 Jun; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 5. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z, Biro FM, Kollar LM, Rauh JL.
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [Abstract] [Full Text] [Related]

  • 6. Depo Provera: a profile of current users.
    Jarman H, Kovacs GT, Westcott M.
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [Abstract] [Full Text] [Related]

  • 7. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z, Biro FM, Kollar LM.
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [Abstract] [Full Text] [Related]

  • 8. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
    Lei ZW, Wu SC, Garceau RJ, Jiang S, Yang QZ, Wang WL, Vander Meulen TC.
    Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
    [Abstract] [Full Text] [Related]

  • 9. Depot medroxyprogesterone acetate use in inner-city, minority adolescents: continuation rates and characteristics of long-term users.
    Lim SW, Rieder J, Coupey SM, Bijur PE.
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1068-72. PubMed ID: 10520615
    [Abstract] [Full Text] [Related]

  • 10. Depressive symptoms and Depo-Provera.
    Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, Heartwell S.
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [Abstract] [Full Text] [Related]

  • 11. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 12. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I, Khan AR, Jahan FA.
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [Abstract] [Full Text] [Related]

  • 13. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 15. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
    Pardthaisong T, Gray RH, McDaniel EB.
    Lancet; 1980 Mar 08; 1(8167):509-12. PubMed ID: 6102234
    [Abstract] [Full Text] [Related]

  • 16. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May 08; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 17. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E, Ikeako LC, Obiora-Okafor NC.
    Niger J Med; 2012 May 08; 21(3):266-71. PubMed ID: 23304918
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov 08; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 19. Depo Provera: still controversial.
    Wren LM.
    Int Health News; 1988 Feb 08; 9(2):2-3, 8. PubMed ID: 12179873
    [Abstract] [Full Text] [Related]

  • 20. Contraceptive implant use among inner city teens.
    Glantz S, Schaff E, Campbell-Heider N, Glantz JC, Bartlett M.
    J Adolesc Health; 1995 May 08; 16(5):389-95. PubMed ID: 7662690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.